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1. Introduction  
The present medicinal system is dominated by the Allopathy or western medicine which is 
prominently taught and practiced in most of the countries world wide. This system is still 
evolving and during last few decades focus was based on chemical origin of most of the 
medicines. Thus majority of drugs in current practice are from synthetic origin. Even so, a 
large number of these synthetic molecules are based directly or indirectly on natural 
products or phytoconstituents (Gupta et al. 2005; Harvey 2008) . The interesting question is – 
what type of medicines were people using for thousands of decades? Another interesting 
futuristic question is – What type of medicine / therapy would emerge and sustain in 
future? Answers to such questions can be obtained by doing a systemic review of existing 
scientific literature and also by making a forecast based on emerging technologies based on 
genetic sciences. Another important arena of brainstorming is how we link such questions 
with each other. We need to understand medicines or systems those were existing in use 
before emergence of current “synthetic era” and visualize the future of medicine and health 
care in the “technology era”. The linkage between “the past” and “the future” of medicine is 
much more important and can give us “new directions” for better understanding health, 
disease and possible solutions. 
Ayurveda, one of the oldest systems used by mankind for well being(Sharma 1995), 
originated in ancient India many thousand years ago (about 4500 BC as agreed by most 
scientists). The origin, development, existence and even practice of Ayurveda has many 
dimensions and complex theories based on religions, faith and ancient Vedic science 
(Patwardhan & Mashelkar 2009). Discussion on all these aspects is beyond the scope of this 
book chapter. Ayurveda, as a system of medicine, is one of the official systems of medicine 
in India (Mashelkar 2008) and is also widely practiced in many other countries (Mashelkar 
2008). Evidence for effectiveness of many ayurvedic drugs and therapies is being generated 
rapidly from many research institutes and also there are projects under way to decipher 
unanswered questions related to Ayurveda. In this chapter we have tried to cover different 
but important aspects which give us a futuristic vision. After giving an overview of basics of 
Ayurveda, a comprehensive review of current status of research in Ayurveda is attempted. 
In later part of the chapter a dialogue on the key term “Drug Rediscovery” is being 
www.intechopen.com
 
Drug Discovery and Development – Present and Future 
 
10
presented for the first time with a scientific perspective. The later part of the chapter also 
covers futuristic discussion where possibilities of linking Ayurveda with drug discovery 
process are described. We have tried to lay down conceptual framework for win-win 
relationship between ancient and contemporary health care sciences backed by strong 
scientific evidence being generated in recent years. We hope to provide innovative material 
for use in further development by scientific fraternity for ultimate benefit of health care and 
humanity.  
1.1 Introduction to Ayurveda 
There exist a plethora of information on Ayurveda through many books and commentaries 
published in past few decades. Most of these books are based on the traditional books which 
are thought to carry the knowledge and know-how of Ayurveda which, in ancient time, was 
existing in the form of memorised shlokas and manuscripts written in Sanskrit language. In 
this part of the chapter we have tried to present brief and comprehensive introduction to 
Ayurveda and its’ fundamentals. The information provided is just a drop in the ocean and 
represents only that which is relevant to understanding the concept of Ayurveda and its 
further use in drug discovery process. 
1.2 What is Ayurveda? 
Ayurveda literally means “science of life” in Sanskrit (Ayur: Life; Veda: Science). It is not 
only a medical system but a way of life. As discussed earlier Ayurveda aims at a holistic 
management of health and diseases. It is widely practiced in the Indian subcontinent and is 
also one of the official systems of medicine in India. Its concepts and approaches are 
considered to have been perfected between 2500-500 BC. 
Charak Samhita and Sushrut Samhita (100-500 BC) are the two main Ayurvedic classics, 
wherein more than 700 plants along with their classification, pharmacological and 
therapeutic properties have been described. Ayurveda during course of ancient times 
developed as sound scientific system and it is evident as it is divided into eight major 
disciplines known as Ashtanga Ayurveda. It is important to note that these specialisations or 
super specialisations were in existence and practiced by experts hundreds of years before 
the emergence of modern Anatomy, physiology and contemporary medicinal system! 
1.3 Fundamentals and perspectives 
1.3.1 Ashtanga Ayurveda: Specialities of knowledge in Ayurveda 
Eight major divisions of Ayurveda have been described and followed for specialized 
knowledge. These categories are:  
1. Kayachikistsa : The closest synonym would be internal medicine,  
2. Shalya: General Surgery,  
3. Shalakya: Speciality dealing with head and neck disorders,  
4. Kaumar-bhritya: obstetrics and pediatrics  
5. Rasayana: geriatrics and rejuvenative/reparative medicine 
6. Vajikaran: Sexology and reproductive medicine,  
7. Agad-Tantra: the body of knowledge on poisons, venoms and toxic substances,  
8. Bhuta-Vidya: infectious diseases and mental illness. The fact that such a systemic 
categorization was established so early speaks of the knowledge and skills being central 
to the practice of Ayurveda. 
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Another fundamental concept of Ayurveda is the well defined system for classifying the 
individuals on basis of their body constitution, physiology and other relevant factors. The 
concept of “Prakruti” is thought to be at the base of many important steps in Ayurvedic 
diagnosis and therapy.  
Prakriti is a consequence of the relative proportion of three entities (Tri-Doshas), Vata (V), 
Pitta (P) and Kapha (K), which are not only genetically determined (Shukra Shonita), but 
also influenced by environment (Mahabhuta Vikara), maternal diet and lifestyle (Matur 
Ahara Vihara), and age of the transmitting parents (Kala -Garbhashaya). 
In an individual, the Tri-Doshas work in conjunction and maintain homeostasis throughout 
the lifetime starting from fertilization. Distinct properties and functions have been ascribed 
to each Dosha. For instance, Vata contributes to manifestation of shape, cell division, 
signaling, movement, excretion of wastes, cognition and also regulates the activities of 
Kapha and Pitta. Kapha is responsible for anabolism, growth and maintenance of structure, 
storage and stability. Pitta is primarily responsible for metabolism, thermo-regulation, 
energy homeostasis, pigmentation, vision, and host surveillance.  
1.4 Drugs of Ayurveda 
Drugs used in Ayurvdea are mostly herbs (crude or processed), minerals products, metals 
(in different oxidised forms prepared by specialised manufacturing techniques) and also 
some times animal products. It is to be noted that in many instances a combination of one or 
more of above type of drugs are prescribed. As per Ayurveda- drugs alone cannot fulfil the 
goal of achieving, improving or maintaining the healthy state of the body. The lifestyle, food 
habits, environment and more importantly the mind plays an important role in Health. Thus 
the Vaidya (Ayurvedic physician) suggests a complete regime which is composed of a set of 
ayurvedic drugs (herbs/ herbo-mineral formulations) to be taken in specified manner in 
combination of food and life style changes are to be followed strictly, to achieve a healthy 
state of mind and body. 
In last few years lots of research has been undertaken on medicinal properties, possible 
mechanisms and other relevant information on many popular herbs mentioned in 
traditional texts and used by Vaidyas. These research projects, mainly pre-clinical studies, 
help to generate evidence behind ayurvedic drugs’ clinical use. Many interesting leads are 
emerging for further drug discovery from Ayurvedic drugs (Patawardhan et al. 2004,). 
These contributions are sometimes forgotten in the current dominance of the reductionist 
paradigm. Table 1 enlists some of the Ayurvedic herbs, which have been widely used and 
subject to pharmacological research. The structural modifications of active principles of 
these plants have led to a plethora of new “chemical” drugs and still there exist a vast 
unexplored arena for SAR based studies which may lead to unique molecules with 
unprecedented safety and efficacy. Since many decades several of these plants are being 
globally used by thousands of licensed Vaidyas and other practitioners and even as a part of 
household tradition. Looking into this background it is desirable to understand the 
Ayurvedic properties of herbs. This approach would assist in evolving innovative 
combinations, investigate new uses and conduct clinical trials with appropriate targets. As 
for example, a judicious and standardized combination of Aloe vera gel and Curcuma longa 
rhizome powder may yield a potent wound and burn healing new product. Similarly, a 
combination of Glycyrrhiza glabra and Zingiber officinale would be more useful in acid-peptic 
disease than the single ingredients. But any such combination must have a rational 
Ayurvedic basis, rather than herbal concoctions. Understanding the ayurvedic basis of any 
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combination of herbs and its use in different condition requires knowledge of ayurvedic 
fundamentals and its correlation with contemporary concepts. Table 1 represent some 
examples of current evidence for ayurvedic drugs and their untapped potential yet to be 
established extending their scientific basis from Ayurveda (Vaidya AB 2006). 
For further information and detailed knowledge readers are advised to study following 
subjects / specialisations of Ayurveda. 
1.5 Ayurvedic pharmaceuticals 
Bhaisajya Kalpana (Ayurvedic Pharmaceutics) forms a branch of Ayurveda, which mainly 
deals with collection and selection of ayurvedic drugs, purification as well as preparation, 
preservation, besides mode of administration and dosage specification. The ancient 
Ayurvedic scholars were very much rational and had a strong scientific background in 
fundamental principles, which are concerned with drug manufacturing. 
Dravyagunavigyana includes identification (pharmacognosy-Namarupa vigyanya), 
preparation (pharmacy-Kalpa Vigyana) and administration (clinical pharmacology-Yoga 
Vigyana). The later deals with the effects of drugs on various systems (pharmacodynamics-
Gunakarma Vigyana) and their application in different diseases (therapeutic-Pryoga 
Vigyana) 
 
Ayurvedic Plant Impact  Untapped potential 
Aloe vera Cosmetopharmaocolgy/ Burns Menopause/Andropause 
Atropa belladona Acetyl choline pharmacology Cigarrete for asthama 
Azadirachta indica Antiinsect/Antifungal Head and neck cancer 
Cassia angustifolia Laxative/Indigetion Chronic infections 
Curcuma longa Antiinflammatory/Antidiabetic Cancer  
Commiphora wightii Antiarthritic/Obesity Tuberculosis/Anti cancer 
Glycyrrhiza glabra Peptic ulcer/Sore throat Anti viral/Anti cancer 
Psoralea coryllifolia Leucoderma/Psoriasis Antimicrobial/Alopecia 
Rauwolfia serpentina Antihypertensive/tranquillizer Antivenom 
Strychnos nux-vomica Digestive/Nervine tonic Glycinergic receptors 
Tinospora cordifolia Immuostimulant/Anticancer Hepatoprotective 
Withania somnifera Sedative/Phytoestrogen Anticancer 
Zingiber officinalis Indigetion/Nausea Arthritis 
Table 1. Ayurvedic plants and impact on therapy and drug discovery  
2. Contemporary drug discovery / development research on Ayurvedic 
concepts and medicines 
As discussed above Ayurvedic concepts differ significantly when it comes to diagnosis, use 
of drugs or even treatment pedagogy. It is well-known that Ayurveda tries to heal or cure 
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any disease condition from its grass-root level. It means, it does not only remove the 
symptoms of the condition, but also alleviates the cause or factors behind the disease. In this 
part of the chapter we would share and discuss few examples of research done on ayurvedic 
concepts and medicines using contemporary technologies or methodologies.  
2.1 Exploring targets - Understanding mechanisms 
There are many studies reported where preclinical or even clinical evidence has been 
generated for understanding targets or even mechanisms for Ayurvedic therapies. Another 
important aspect of research is to correlate ayurvedic fundamentals behind etiology, disease 
progression and its possible interventions in terms of contemporary medical/life science. 
2.2 Correlating ancient science with contemporary pathophysiology and medicinal 
system 
An article published by Sharma and Chandola, discusses the details of “Prameha” of 
Ayurveda and its correlation with obesity, metabolic syndrome, and diabetes mellitus 
(Sharma& Chandola 2011). The authors have given scientific basis of correlation and have 
described etiology, classification, and pathogenesis of these conditions both in terms of 
ayurvedic and modern concepts. According to this article there are 20 subtypes of Prameha 
due to the interaction of the three Doshas and 10 Dushyas (disturbed functioning of the 
principles that support the various bodily tissues); several of these subtypes have sweet 
urine, whereas some of them have different coloration of the urine, highlighting the 
inflammatory conditions involved in the metabolic syndrome. This disease has close ties to 
Sthaulya (i.e., obesity). With regard to diabetes mellitus, Sahaja Prameha and Jatah Pramehi 
correlate with type 1 diabetes; Apathyanimittaja Pramehacorrelates with type 2 diabetes. 
Madhumeha is a subtype of Vataja Prameha (Prameha withVata predominance) that can 
occur as the terminal stage of type 2 diabetes (in which insulin is required), or as type 1 
diabetes beginning in early childhood. The latter is defined as Jatah Pramehi Madhumehino 
in Charaka Samhita, one of the classical Ayurvedic texts. The authors have concluded that 
various dietary, lifestyle, and psychologic factors are involved in the etiology of Prameha, 
particularly in relation to disturbances in fat and carbohydrate metabolism. The ancient 
Ayurvedic knowledge regarding Prameha can be utilized to expand the current 
understanding of obesity, metabolic syndrome, and diabetes. 
2.3 Discovery through pre-clinical studies for understanding mechanism and targets 
for Ayurvedic drugs 
As discussed earlier there are many papers being published regularly in national and 
international journals which provide evidence based on pre clinical studies and also some 
times provide probable mechanism of the ayurvedic drug / formulation under study. Few 
such examples are quoted here to reiterate the fact that ayurvedic drugs and therapies are 
having sound scientific background and one of the primary things remaining is to generate 
evidence so as to understand their utility and mechanism from contemporary science’s point 
of view. In 2009 our team published results for understanding the immunomodulatory 
effect of “Shatavri” (Asparagus racemosus). Shatavri is one of the reputed and widely used 
rasayana herb of Ayurveda and is responsible for providing rejevunating effect along with 
other beneficial effects. In this article mixed Th1/Th2 activity of shatavri extracts is proven 
supporting its immunoadjuvant potential (Gautam et al. 2009).  
www.intechopen.com
 
Drug Discovery and Development – Present and Future 
 
14
In another mechanistic study Chondroprotective potential of Extracts of Almalki Fruits 
(Phyllanthus emblica) in Osteoarthritis was undertaken to understand mechanism behind the 
traditional use of Almalki. Chondroprotection was measured in three different assay 
systems. First, the effects of fruit powder were studied on the activities of the enzymes 
hyaluronidase and collagenase type 2. Second, an in vitro model of cartilage degradation 
was set-up with explant cultures of articular knee cartilage from osteoarthritis patients. 
Cartilage damage was assayed by measuring glycosaminoglycan release from explants 
treated with/without P. emblica fruit powders. Aqueous extracts of both fruit powders 
significantly inhibited the activities of hyaluronidase and collagenase type 2 in vitro. Third, 
in the explant model of cartilage matrix damage, extracts of glucosamine sulphate and 
selected extract exhibited statistically significant, long-term chondroprotective activity in 
cartilage explants from 50% of the patients tested (Sumantran et al. 2008).   
2.4 Clinical evidence for medicinal uses of Ayurvedic drugs 
Apart from pre-clinical studies many clinical studies of various depths are also being 
reported recently. Additionally the Government of India supported Department of AYUSH 
undertakes many clinical research based projects on prioritised ayurvedic medicines and 
formulations. One of the clinical studies we would like to quote here as reference is for 
studying efficacy of standardised ayurvedic formulation in arthritis. The multidisciplinary 
“New Millennium Indian Technology Leadership Initiative” Arthritis Project was supported 
by Government of India. It included randomised controlled exploratory trial with Zingiber 
officinale and Tinospora cordifoliaas as main drugs in the formulations under study. Total 245 
eligible patients suffering from symptomatic osteo arthritic knees gave consent for it and 
were randomized into seven arms (35 patients per arm) of a double blind, parallel efficacy, 
and multicentre drug trial of sixteen weeks duration. The trial was controlled for placebo 
and glucosamine sulphate use. No dietary or other restrictions were advised. The groups 
matched well at baseline. There were no differences between the groups for patient 
withdrawals (total forty three) or adverse events (AE) which were all mild. In an intention-
to-treat primary efficacy analysis, there were no significant differences (P < .05) for pain 
(weight bearing) and WOMAC questionnaire (knee function); a high placebo response was 
recorded. Based on better pain relief, significant (P < .05) least analgesic consumption, and 
improved knee status, one of the formulations under study “C” formulation was selected for 
further development. This study gives overview suggesting that how the clinical research on 
ayurvedic herbs or formulations can generate the evidence and also in understanding their 
possible mechanism of action (Chopra et al. 2011).  
2.5 Clinical evidence for Ayurvedic therapy 
As discussed earlier most of the time Ayurvedic physicians undertake different approaches 
for treatment where multiple drugs or formulations are used at one or different stages 
therapy. One such popular approach in Ayurveda is “Pachkarma therapy” which is used for 
variety of conditions where detoxification is required to cope up with stress or unbalanced 
physiology. Ayurvedic drugs or formulations used in such therapy can lead to a very 
different approach of drug discovery where multiple drugs are working together on 
multiple targets to achieve the objective of balancing the body physiology.  
One such study is reported by Tripathi et al. (2010). This was a comparative clinical trial on 
the role of Panchakarma therapy and Unmada Gajankusha Rasa in the cases of major 
depressive disorder vis-à-vis kaphaja Unmada.  
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2.6 Safety pharmacology and drug interaction studies as part of drug discovery based 
on ayurvedic drugs 
In contemporary Drug discovery programs safety has prime importance and any molecule 
must have a favorable risk benefit ratio to be considered and approved as drug. Even 
though ayurvedic drugs and/or formulations are in use by public and vaidyas since 
antiquities, most of them have a proven record of safety and tolerability. Any change or 
deviation in method of preparation or use other then that mentioned in traditional text 
requires additional studies to evaluate safety. Another safety aspect includes understanding 
of drug interactions if ayurvedic drugs are to be taken with other form of medicines. These 
sub parts of drug discovery process can be addressed by undertaking invitro toxicology 
studies and pharmacokinetic studies to understand drug interactions. In one of the studies 
we have reported Safety Pharmacology and Drug Interaction aspects of Cassia auriculata. In 
this study routine safety pharmacology with focus on cardiovascular variables and 
pharmacokinetic herb-drug interaction studies on rats fed with standardized traditional 
hydro-alcoholic extract and technology-based supercritical extract of Cassia auriculata for 12 
weeks were undertaken. These studies indicate that both these extracts are 
pharmacologically safe and did not show any significant adverse reactions at the tested 
doses. The traditional hydro-alcoholic extract did not show any significant effect on 
pharmacokinetics; however, the technology-based supercritical extract caused a significant 
reduction in absorption of Metformin (Puranik et al. 2011).  
These and many other such studies describe the way of incorporation of safety aspect in 
drug discovery process for Ayurvedic drugs. 
3. Concept of “Drug rediscovery” 
Contemporary Drug discovery and development (DD) process is becoming longer and 
expensive. Establishing the right balance between efficacy and safety is the crucial part of 
DD process. As the chemical entity under study would be completely new and no prior 
human exposure is reported, there are chances of many unexpected side effects being 
observed at various stages of development. These require multiple efforts for optimisation 
of the molecule for its safety and efficacy and many times the molecule under study has to 
be dropped from study due to high toxicity or side effects. 
Most ayurvedic drugs / herbs are in use since times immemorable and experience of 
thousands of physicians is available to vindicate their safety and efficacy. Thus drug 
discovery process needs to be modified if benefits from Ayurvedic science are to be tapped. 
Many scholars have previously reported different approaches for this. “Reverse 
pharmacology” approach starts with clinical studies and goes upto the mechanistic pre-
clinical studies (Patwardhan 2004).  
Here we deploy a term “Drug rediscovery” which is more relevant for research involving 
ayurvedic herbs and drugs. As ayurvedic drugs are already in use as part of medicinal 
system any further research on these drugs would aid only in understanding their 
mechanisms and / or help in optimising their doses either alone or in combination. Thus the 
term “Drug rediscovery” would help differentiate process of discovering a drug from totally 
new chemical entity from the process of understanding a drug which is not totally new to 
mankind.  
Another extension of Drug rediscovery from ayurvedic drugs can be done for benefit of 
contemporary science of medicine and that would be “stage 2 drug discovery” based on 
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results of research done during drug rediscovery of ayurvedic drugs and herbs. This stage  
2 DD would start only after bio-marker based research which is a part of Drug rediscovery 
of ayurvedic drugs. This may generate to newer leads with multiple targets and can give 
new direction to speed up the existing discovery path adopted. This concept is explained in 
Table 2.  
 
 
Table 2. Unique potential of Ayurvedic Drugs for Drug (Re)discovery 
3.1 Accelerated clinical research 
The process of rediscovering a drug on basis of its ayurvedic origin involves reverse 
pharmacology and requires different approaches for undertaking clinical research. One of 
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the approaches can be retrospective study based on hospitals’ or clinicians’ (vaidya in most 
of the cases) practice of particular disease or herb. This would be little difficult looking into 
differences in documentation and record keeping practices in most of the parts of India 
where Ayurveda is regularly practiced. Another approach for undertaking clinical study can 
be based on Reverse pharmacology where drug under study can be selected on basis of its 
clinical use and field experience. We have already discussed one such study earlier in this 
chapter where randomized, controlled exploratory clinical study on ayurvedic formulation 
was done for its use in osteoparthritic conditions (Chopra et al. 2011). This study along with 
standardization of formulation was completed in 23 months and thus the time of generation 
of evidence is comparatively low as that of contemporary discovery of newer molecules. 
Even WHO had published guideline mentioning different requirements for clinical research 
on Traditional medicines (2000). Thus the concepts of “Reverse pharmacology” and “Drug 
Rediscovery” through Ayurvedic drugs can significantly reduce the time-lag between 
induction of research project and clinical evidence generation through scientifically 
designed clinical research.  
3.2 AyuGenomis: Role in future of drug discovery  
Biotechnology with its specialisations like genomics, proteomics, genetic engineering etc. 
has made immense advances in deciphering diseases conditions, disease progression, 
prognosis and even up-to certain level cure for particular conditions. Genomics can play 
important role both in prevention and treatment of many diseases (Steinberg et al. 2001). 
The advanced technologies used in genomics and related sciences can help understanding 
role of genes in diseases and health. The use of these technologies and concepts for 
generating scientific evidence behind concepts of Ayurveda can open up many interesting 
avenues.  
Structural and functional genetic differences in humans can take the form of single 
nucleotide polymorphisms (SNP), copy number variations (CNVs), and epigenetic or gene 
expression modifications. As per current research, in human 99.5 % genetic similarity is 
found and almost all physiological or anatomical variations amongst person to person are 
due to 0.5% diversity in single nucleotide polymorphism (SNP) and other variations in 
nucleotides (Levy et al. 2007). These inherited inter-individual variations in DNA sequence 
contribute to phenotypic variation, influencing an individual's anthropometric 
characteristics, risk of disease and response to the environment. Characterizing genetic 
variation may bring improved understanding of differential susceptibility to disease, 
differential drug response, and the complex interaction of genetic and environmental 
factors, which go to produce each phenotype. 
Ayurveda, the traditional system of Indian medicine, Traditional Chinese medicine and 
Korean medicine all have well-defined systems of constitutional types used in prescribing 
medication bearing distinct similarities to contemporary pharmacogenomics. The 
pharmacognenomics can become useful for understanding genetic basis of concept of 
“Prakriti”. This part of the chapter would discuss about how Pharmacogenomics and 
Ayurveda can be researched together for unpacking vast possibilities of integrated science. 
According to Ayurveda an individual’s basic constitution to a large extent determines 
predisposition and prognosis to diseases as well as therapy and life-style regime. 
Importance of such individual variations in health and disease is an important basic 
principle of ayurveda and was underlined by Charaka sometime 4000 years ago as follows:  
www.intechopen.com
 
Drug Discovery and Development – Present and Future 
 
18
‘Every individual is different from another  
and hence should be considered as a different entity.  
As many variations are there in the Universe, all are seen in Human being’. 
In the Ayurveda system of medicine, predisposition to a disease as well as selection of a 
preventive and curative regime is primarily based on phenotypic assessment of a person 
which includes one’s body constitution termed “Prakriti”. The concept of Prakriti is already 
discussed in detail earlier in this chapter. 
The phenotypic diversity, according to Ayurveda, is a consequence of a continuum of 
relative proportions of Doshas resulting in seven possible constitutional types namely Vata 
(V), Pitta(P), Kapha(K), Vata-Pitta, Pitta-Kapha, Vata-Kapha and Vata-Pitta-Kapha. 
Amongst these, the first three are considered as extremes, exhibiting readily recognizable 
phenotypes, and are more predisposed to specific diseases. 
Better characterization of the human genome has improved the scientific basis for 
understanding individual variation. The Ayurvedic Prakriti concept should be examined 
from a genomic perspective. Permutations and combinations of V, P, K attribute characters 
along with other host factors such as tissue status (Dhatusarata), twenty Gunas, digestive 
capacity and metabolic power (Agni), psychological nature (Manas Prakriti), habitat 
(Desha), and season (Kaala), lead to sufficient numbers of variants to define a unique 
constitution for every individual. Ayurveda thus describes the basis of individual 
variation(Bhushan 2007). 
In the realm of modern predictive medicine, efforts are being directed towards capturing 
disease phenotypes with greater precision for successful identification of markers for 
prospective disease conditions. 
Ayurveda has been investigated for this purpose, based on the hypothesis that Prakriti types 
(V, P and K) may offer phenotypic datasets suitable for analysis of underlying genetic 
variation. As a proof of concept, in the first study done by us, we evaluated 76 subjects both 
for their Prakriti and HLA DRB1 types, finding significant correlations in support of it 
(Patwardhan et al. 2005). The study concluded that Ayurveda based phenomes may provide 
a model to study multigenic traits, possibly offering a new approach to correlating 
genotypes with phenotypes for human classification. 
The three major constitution types described in Ayurveda have unique putative metabolic 
activities, K being slow, P fast, while V is considered to have variable metabolism. We 
hypothesized that this might relate to drug metabolism and genetic polymorphism of drug 
metabolizing enzymes (DME). Inter-individual variability in drug response can be 
attributed to polymorphism in genes encoding different drug metabolizing enzymes, drug 
transporters and enzymes involved in DNA biosynthesis and repair. Gene polymorphisms 
precipitate in different phenotypic subpopulations of drug metabolizer. Poor metabolizers 
(PM) have high plasma concentration of the drug for longer periods and so retain drugs in 
the body for longer times. Intermediate metabolizers retain drugs in the body for normal 
time periods. Extensive metabolizers (EM) retain drugs in the body for the least time, 
plasma concentrations being high for shorter periods. 
In another study we investigated the distribution of drug metabolizing enzymes CYP2C19 
and CYP2C9 genotypes in 132 healthy individuals of different Prakriti classes(Ghodke et al. 
2009). The results obtained suggest possible association of CYP2C19 gene polymorphism 
with Prakriti phenotypes. 
Overview of few such studies are given in Table No 3 which gives successful lead to new 
directions for further research.  
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medicine/intervention target/enzyme no. of person Output Ref. no 
corelation between Human 
Leucocytes Antigen(HLA) 
and prakriti type 
HLA DRB1 gene 
 
Total 76 person
10 - vata 
32 – kapha 
34 – pitta 
prakriti 
There is complete absence 
of HLA DRB1*02 in Vata 






Polymorphism and prakriti 
type associated with 
metabolic activity 
CYP2C19  





The extensive metabolizer 
(EM) genotype was 
predominant in Pitta 
Prakriti (91%), Poor 
metabolizer (31%) in 
Kapha Prakriti when 
compared with Vata 
(12%) and Pitta Prakriti 
(9%). 








 substances’ similarities of 
‘Rasa’ may indicate 
similar pharmacological 
activity & assumes a new 
significance to distinguish 
all the kinds of molecule
 
(Joshi et al. 
2007) 
The molecular correlation 















The extreme constitution 
types revealed differences 
at gene expression level, 
biochemical levels. It 
provide a strong basis for 
integration of this holistic 
science with modern 
genomic approaches for 
predictive marker 
discovery and system 
biology studies. 
(Prasher 
et al. 2008) 
EGLN1 involvement in 
high-altitude adaptation 
revealed through genetic 
analysis of extreme 
constitution types defined in 
Ayurveda 
EGLN1 is a key 







TT genotype of rs479200 
was more frequent in 
Kapha types and 
correlated with higher 
expression of EGLN1, was 
associated with patients 
suffering from high-
altitude pulmonary 
edema, whereas it was 
present at a significantly 
lower frequency in Pitta 
and nearly absent in 
natives of high altitude. 
(Aggarwal 
et al. 2010) 
Table 3. Advanced studies on Ayurvedic fundamentals 
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Thus it can be summarised that identification of genetic variations underlying metabolic 
variability in Prakriti may provide newer approach to Pharmacogenomics. Extensive studies 
on Prakriti subtypes and genome wide single nucleotide polymorphism (SNP) mapping 
especially of other important DME polymorphisms like CYP2D6, CYP2C9, CYP3A4, TPMT, 
etc., would be useful to understand possible Prakriti pharmacogenomics relationship 
correlating genotype, Prakriti and drug metabolism. 
Thus, these studies support that Ayurveda Classification is based on genome differentiation 
and having correlation with different drug responses and adverse effect. The Ayurvedic 
classification shows similar principle of pharmacogenomics for selecting “right drug, right 
dosage and to the right patient”. There are many such studies required to prove the scientific 
basis of many of the un-deciphered complex Ayurvedic principles and fundamentals given in 
Vedic science of life. It seems that thousands of years before, Ayurvedic experts had known 
effect of genetic variation on physiology and pharmacology much more in details and current 
scientific tools fell short of understanding such complex concepts of Ayurveda.  
An integration of traditional systems of medicine(Ayurveda, TCM, SCM, Kampo) with 
pharmacogenomics utilizes the advantage of high throughput DNA sequencing, gene 
mapping, and bioinformatics to identify the actual genetic basis of ‘interindividual’ and 
‘interracial’ variation in drug efficacy and metabolism and holds promise for future 
predictive and personalized medicine. 
Combining the strengths of the knowledge base of traditional systems of medicine with the 
dramatic power of combinatorial sciences and HTS will help in the generation of structure–
activity libraries which will converge to form a real discovery engine that can result in 
newer, safer, cheaper and effective therapies. 
The traditional systems of medicine in Asia (Ayurveda, TCM, SCM, Kampo) are considered 
great living traditions. They are all closely related to each other. For example, all are based 
on theories of constitution. All identify unique qualities of each individual, and state the 
necessity of developing personalized medicine in order to obtain optimal response to 
treatment. This is similar to the science of Pharmacogenomics, which tries to identify 
individual differences between patients connected to drug metabolism, efficacy and toxicity 
at the genomic level. Current research in 'Omics' is focusing on the polygenic approach 
using high throughput technology rather than the single gene approach. 
Such research found a genetic basis for the classification of physical constitution in 
traditional medicine. “These observations are likely to have an impact on phenotype-
genotype correlation, drug discovery, pharmacogenomics and personalized medicine.” So, 
“Identifying genetic variations in Asia-based constitution may provide a newer approach to 
pharmacogenomics and help better understand the scientific classification basis of human 
population for better therapeutic benefits.” 
4. Current status: Promises and bottle necks 
4.1 Appraisals or evidence for importance of Ayurveda 
The evidence is what is required to prove an idea or concept or even a system. There exist 
plethora of evidence for scientific basis of Ayurveda (Mishra 2003; Patwardhan& Mashelkar 
2009; Vaidya AB 2006) and one needs to adopt an unbiased neutral opinion to see the 
promising way forward for drug discovery with support of Ayurveda. Because ancient 
sciences are not limited to one religion or geographical area, they should be used for benefit 
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of health care system in totality. The promising outputs are already available where 
Ayurveda has given many miracle drugs like Ashwagandha (Withania somnifera, Family: 
Solanaceae), Guggul (Commiphora wightii, F: Burseraceae), Shatavari (Asparagus racemosus,  
F: Asparagaceae), Brahmi(Centella asiatica, F: Mackinlayaceae), Neem (Azadirachta indica,  
F: Meliaceae), Turmeric (Curcuma longa, F: Zingiberaceae), Isabgul (Plantago ovata,  
F: Plantaginaceae) so on and so forth. These drugs can be used both in traditional forms as 
well as in form of standardized semipurified or purified phytopharmaceuticals. These 
plants or their parts are regulated differently in different countries. As per Ayurvedic 
system of medicine they are licensed as drugs and are in Clinical use in India. As these 
drugs are not fully standardised or as currently there is no globally accepted common 
regulations for herbals they can be considered as herbal supplement or functional food etc. 
The research on preclinical, clinical, Phytochemical, Pharmacokinetics-Pharmacodynemics 
(PK-PD), safety pharmacology etc. for ayurvedic drugs and formulations are on surge and 
world needs to have more integrative and planned approach so as to leverage the benefit of 
this tie-up between ancient and contemporary sciences.  
4.2 Possible bottle necks 
As many concepts of Ayurveda are more of integrated nature it needs inputs from many 
branches of science. As for example personalized medicine concept is an integral part of 
Ayurveda and is based on “Prakriti” of an individual which affects the choice of medicine 
and the way the particular health condition is treated though Ayurveda. This paradigm is 
into its infancy in modern science where we are still trying to understand genetic variations 
and their links with diseases and physiology. One of the possible bottlenecks can be lack of 
scientific tools which help to understand the detailed concepts of Ayurveda. 
Another bottle neck that is already under debate is “marker” based evaluation of herbs. 
Traditionally ayurvedic herbs are used in crude form (and not as isolated or purified 
compounds) and many a times in combination with other herbs or preparations and thus 
science behind chemistry of such complex mixtures is yet to be evolved. Even though 
Ayurveda has provided many promising leads in terms of isolated molecules it is different 
part of story where individual phytoconstituents are studied as drugs. Thus we need to 
differentiate between traditional ayurvedic drugs and modern form of phyto-constituent 
based drugs (Patwardhan& Mashelkar 2009).  
5. Win-win situation for future of health care 
To conclude this chapter we would like to elaborate various points where ancient science of 
Ayurveda and contemporary health care stream can gain from each other for far reaching 
benefits and newer directions of drug discovery and health. 
Table No. 4 discusses benefits that can be gained by Ayurveda and contemporary science.  
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 Benefits for Ayurveda Benefits for drug discovery / 




- Understanding of chemistry 
behind success of ayurvedic herbs.
- Better understanding of chemical 
transformation during traditional 
manufacturing practices 
 
- Availability of new leads 
based on SAR studies of 
phytoconstituents. 
- Herbo-mineral formulations 
mixed with plants provide 
unique combination for 
studying interaction between 





- Ability to provide uniform and 
consistent products using 
analytical and standardisation 
techniques 
- Traditional manufacturing 
techniques can be improved using 
modern unit operation based 
techniques. 
- Traditional ayurvedic 
manufacturing techniques 
involve unique type of 
processes which can form 
basis of improved unique 
processes of purification, 





- better understanding of 
mechanisms of individual herbs 
using invitro techniques 
- better understanding of 
mechanisms of polyherbal 
formulations using in-vivo animal 
models 
- Understanding genetic basis of 
prakriti and tri-dosha based 
classification of humans 
- Improved understanding of 
correlation between mind and 
body linked with quantum 
physics / chemistry 
- Newer approaches for 
maintaing health and /or 
treating diseased conditions. 
- Understanding of link 
between life style, 
environment and health 
Table 4. Win-win situation for Ayurveda, contemporary drug discovery process and health 
care sciences 
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